{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:31:44Z","timestamp":1784716304175,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["1943900"],"award-info":[{"award-number":["1943900"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000835","name":"University of Bath","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-PG2018-003"],"award-info":[{"award-number":["ARUK-PG2018-003"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jbc.2022.102565","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T01:48:47Z","timestamp":1664934527000},"page":"102565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anionic lipid vesicles have differential effects on the aggregation of early onset-associated \u03b1-synuclein missense mutants"],"prefix":"10.1016","volume":"298","author":[{"given":"Kathryn J.C.","family":"Watt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2369-1989","authenticated-orcid":false,"given":"Robert J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-1958","authenticated-orcid":false,"given":"Jody M.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102565_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jbc.2022.102565_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2022.102565_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of \u03b1-synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2022.102565_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2007.11.016","article-title":"Screening PARK genes for mutations in early-onset Parkinson\u2019s disease patients from Queensland, Australia","volume":"15","author":"Mellick","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.22365","article-title":"Familial Parkinsonism and early onset Parkinson\u2019s disease in a Brazilian Movement Disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1 and LRRK2 mutations","volume":"24","author":"Camargos","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/ene.12315","article-title":"Genetic assessment of familial and early-onset Parkinson\u2019s disease in a Greek population","volume":"21","author":"Bozi","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/mds.28534","article-title":"A\u00a0novel SNCA A30G mutation causes familial Parkinson\u02bcs disease","volume":"36","author":"Liu","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2022.102565_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A\u00a0novel \u03b1-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2022.102565_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2022.102565_bib15","doi-asserted-by":"crossref","first-page":"2180e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A\u00a0novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jbc.2022.102565_bib16","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1212\/NXG.0000000000000027","article-title":"Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation","volume":"1","author":"Martikainen","year":"2015","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jbc.2022.102565_bib17","doi-asserted-by":"crossref","first-page":"248e7","DOI":"10.1016\/j.neurobiolaging.2017.05.022","article-title":"Homozygous alpha-synuclein p.A53V in familial Parkinson\u2019s disease","volume":"57","author":"Yoshino","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jbc.2022.102565_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1021\/acschemneuro.8b00579","article-title":"Different effects of \u03b1-synuclein mutants on lipid binding and aggregation detected by single molecule fluorescence spectroscopy and ThT fluorescence-based measurements","volume":"10","author":"Ruf","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2022.102565_bib19","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jbc.2022.102565_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102565_bib22","first-page":"a009399","article-title":"\u03b1-Synuclein in Parkinson\u2019s disease","volume":"4","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jbc.2022.102565_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/cib.3.2.10964","article-title":"The regulation of synaptic function by \u03b1-synuclein","volume":"3","author":"Bellani","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchemneu.2010.12.001","article-title":"The role of alpha-synuclein in neurotransmission and synaptic plasticity","volume":"42","author":"Cheng","year":"2011","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.jbc.2022.102565_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson\u2019s disease - lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2022.102565_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib28","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib29","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Stroh\u00e4ker","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102565_bib30","first-page":"S51","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J.\u00a0Park. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104876","article-title":"Do Lewy bodies contain alpha-synuclein fibrils? And does it matter? A brief history and critical analysis of recent reports","volume":"141","author":"Lashuel","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2174","article-title":"Insights into the molecular mechanism of amyloid filament formation: segmental folding of \u03b1-synuclein on lipid membranes","volume":"7","author":"Antonschmidt","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2022.102565_bib33","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/ja209019s","article-title":"Structural intermediates during \u03b1-synuclein fibrillogenesis on phospholipid vesicles","volume":"134","author":"Comellas","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2022.102565_bib34","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1021\/acs.jpclett.9b03005","article-title":"Lipid dynamics and phase transition within \u03b1-synuclein amyloid fibrils","volume":"10","author":"Galvagnion","year":"2019","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.jbc.2022.102565_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41531-020-00122-1","article-title":"A\u00a0series of helical \u03b1-synuclein fibril polymorphs are populated in the presence of lipid vesicles","volume":"6","author":"Meade","year":"2020","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-019-0095-3","article-title":"Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let\u2019s talk about the lipids in the room","volume":"5","author":"Killinger","year":"2019","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib37","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","article-title":"The role of lipids in \u03b1-synuclein misfolding and neurotoxicity","volume":"294","author":"Ugalde","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib38","first-page":"433","article-title":"The role of lipids interacting with \u03b1-synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J.\u00a0Park. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00175","article-title":"Lipids at the crossroad of \u03b1-synuclein function and dysfunction: biological and pathological implications","author":"Alza","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jbc.2022.102565_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson\u2019s disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.jbc.2022.102565_bib41","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","article-title":"Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles","volume":"99","author":"Middleton","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2022.102565_bib42","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/cells10092452","article-title":"Alpha-synuclein and lipids: the elephant in the room?","volume":"10","author":"Sarchione","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2022.102565_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183536","article-title":"Interactions of \u03b1-synuclein oligomers with lipid membranes","volume":"1863","author":"Musteikyt\u0117","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jbc.2022.102565_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","article-title":"Molecular anatomy of a trafficking organelle","volume":"127","author":"Takamori","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.102565_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2022.102565_bib46","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1042\/BCJ20170200","article-title":"\u03b1-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking","volume":"474","author":"Lou","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102565_bib47","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.1601899113","article-title":"Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein","volume":"113","author":"Galvagnion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human \u03b1-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2022.102565_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbrc.2018.11.200","article-title":"Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates","volume":"508","author":"Tanaka","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2022.102565_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.12806","article-title":"Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of \u03b1-synuclein","volume":"131","author":"Rutherford","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2022.102565_bib51","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1073\/pnas.1604645113","article-title":"Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation","volume":"113","author":"Flagmeier","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib52","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102565_bib53","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in\u00a0vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2022.102565_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala 30 to Pro and Ala 53 to Thr on the physical and morphological properties of \u03b1-synuclein protein implicated in Parkinson\u2019s disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2022.102565_bib55","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1021\/bi400999d","article-title":"The Parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-synuclein aggregation in\u00a0Vitro","volume":"52","author":"Ghosh","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102565_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib57","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2022.102565_bib58","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102565_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2022.102565_bib60","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1529\/biophysj.107.127464","article-title":"Concentration dependence of \u03b1-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory","volume":"95","author":"van Raaij","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2022.102565_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Malmos","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2022.102565_bib62","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2022.102565_bib63","doi-asserted-by":"crossref","first-page":"16863","DOI":"10.1073\/pnas.1002867107","article-title":"Protein-induced photophysical changes to the amyloid indicator dye thioflavin T","volume":"107","author":"Wolfe","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib64","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of \u03b1-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2022.102565_bib65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","article-title":"Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P \u03b1-Synuclein","volume":"315","author":"Jo","year":"2002","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib66","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate \u03b1-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib67","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1074\/jbc.M111.306902","article-title":"Mutant protein A30P \u03b1-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics","volume":"287","author":"Lemkau","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib69","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic \u03b1-synuclein filaments shows amyloid-like cross-\u03b2 conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib70","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/bi7000246","article-title":"The impact of the E46K mutation on the properties of \u03b1-synuclein in its monomelic and oligomeric states","volume":"46","author":"Fredenburg","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102565_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2017.04.004","article-title":"Natural product-based amyloid inhibitors","volume":"139","author":"Velander","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102565_bib72","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in \u03b1-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib73","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson\u2019s disease linked mutation G51D attenuates in\u00a0vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102565_bib74","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human a-synucleins assemble into elongated filaments with distinct morphologies in\u00a0Vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib75","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human \u03b1-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102565_bib76","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib77","article-title":"DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data","author":"Miles","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2022.102565_bib78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbc.2022.102565_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Met."},{"key":"10.1016\/j.jbc.2022.102565_bib80","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1087057115625190","article-title":"Characterization of differentiated SH-SY5Y as neuronal screening model reveals increased oxidative vulnerability","volume":"21","author":"Forster","year":"2016","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.jbc.2022.102565_bib81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48907","article-title":"Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy","volume":"8","author":"Guerrero-Ferreira","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2022.102565_bib82","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.1917914117","article-title":"The \u03b1-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure","volume":"117","author":"Boyer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib83","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102565_bib84","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41594-019-0322-y","article-title":"Structures of fibrils formed by \u03b1-synuclein hereditary disease mutant H50Q reveal new polymorphs","volume":"26","author":"Boyer","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib85","first-page":"1","article-title":"Parkinson\u2019s disease associated mutation E46K of \u03b1-synuclein triggers the formation of a distinct fibril structure","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102565_bib86","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41422-020-0299-4","article-title":"Cryo-EM structure of full-length \u03b1-synuclein amyloid fibril with Parkinson\u2019s disease familial A53T mutation","volume":"30","author":"Sun","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2022.102565_bib87","doi-asserted-by":"crossref","first-page":"20305","DOI":"10.1073\/pnas.1922741117","article-title":"Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM","volume":"117","author":"Zhao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102565_bib88","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/s41467-021-26433-2","article-title":"The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type \u03b1-synuclein","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102565_bib89","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.jmb.2019.07.001","article-title":"Structural\u00a0insights into \u03b1-synuclein fibril polymorphism: effects of Parkinson\u2019s disease-related C-terminal truncations","volume":"431","author":"Ni","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102565_bib90","article-title":"Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains","author":"Burger","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2022.102565_bib91","article-title":"Different structures and pathologies of \u03b1-synuclein fibrils derived from preclinical and postmortem patients of Parkinson\u2019s disease","author":"Fan","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2022.102565_bib92","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psych."},{"key":"10.1016\/j.jbc.2022.102565_bib93","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.56.10.1355","article-title":"Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers","volume":"56","author":"Kr\u00fcger","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2022.102565_bib94","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/mds.20581","article-title":"Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy","volume":"20","author":"Zarranz","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2012.08.001","article-title":"Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the \u03b1 synuclein gene","volume":"19","author":"Tijero","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib96","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.parkreldis.2015.03.011","article-title":"Parkinson disease: \u03b1-Synuclein mutational screening and new clinical insight into the p.E46K mutation","volume":"21","author":"Pimentel","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.jbc.2022.102565_bib97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jbc.2022.102565_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-015-0038-3","article-title":"Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation","volume":"10","author":"Kiely","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2022.102565_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2015.04.022","article-title":"The A53E \u03b1-synuclein pathological mutation demonstrates reduced aggregation propensity in\u00a0vitro and in cell culture","volume":"597","author":"Rutherford","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2022.102565_bib100","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1021\/acs.biochem.8b00314","article-title":"Comparison of kinetics, toxicity, oligomer formation, and membrane binding capacity of \u03b1-synuclein familial mutations at the A53 site, including the newly discovered A53V mutation","volume":"57","author":"Mohite","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102565_bib101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib102","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","article-title":"Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding a-synuclein","volume":"65","author":"Athanassiadou","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jbc.2022.102565_bib103","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410400513","article-title":"Clinical genetic analysis of Parkinson\u2019s disease in the Contursi kindred","volume":"40","author":"Golbe","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2022.102565_bib104","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.12688\/f1000research.12193.1","article-title":"Multiple system atrophy: genetic risks and alpha-synuclein mutations","volume":"6","author":"Whittaker","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.jbc.2022.102565_bib105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2022.102565_bib106","doi-asserted-by":"crossref","first-page":"166706","DOI":"10.1016\/j.jmb.2020.11.005","article-title":"The library derived 4554W peptide inhibits primary nucleation of a-synuclein","volume":"432","author":"Meade","year":"2020","journal-title":"J. Mol. Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822010092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822010092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:26:22Z","timestamp":1758241582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822010092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0021925822010092"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102565","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anionic lipid vesicles have differential effects on the aggregation of early onset-associated \u03b1-synuclein missense mutants","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102565"}}